Education
About Us
Working with TipRanks
Follow Us
Adele Gulfo Insider Profile
4 Followers
Adele Gulfo, Director at Bemis Company, holds 4.86K shares in Enpro (Ticker: NPO), holds 14.26K shares in NewAmsterdam Pharma Company (Ticker: NAMS), holds 0.00 shares in Myovant Sciences (Ticker: MYOV).
Adele Gulfo Bemis Company (BMS)Director
Bemis Company (BMS)
Director
Not Ranked
Adele Gulfo has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Adele Gulfo holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Adele Gulfo
Adele Gulfo's Trading History
Bemis Company
Jun 11, 2019
―
Uninformative Sell
―
$0.00
Enpro
Feb 12, 2026
Director
Uninformative Buy
140.00K
$1.32M
Myovant Sciences
Mar 10, 2023
―
Uninformative Sell
―
$0.00
Tyra Bioscience
―
Director
―
―
NewAmsterdam Pharma Company
Jan 09, 2026
Director
Uninformative Buy
―
$493.82K
List of latest transactions for each holding click on a transaction to see Adele Gulfo's performance on stock
You May Also Like
Adele Gulfo insider profile FAQ
What is the percentage of profitable transactions made by Adele Gulfo?
The percentage of profitable transactions made by Adele Gulfo is ―.
What is the average return per transaction made by Adele Gulfo?
The average return per transaction made by Adele Gulfo is ―.
What stocks does Adele Gulfo hold?
Adele Gulfo holds: BMS, NPO, MYOV, TYRA, NAMS stocks.
What was Adele Gulfo’s latest transaction?
Adele Gulfo latest transaction was an Uninformative Buy of $140.00K.
What was Adele Gulfo's most profitable transaction?
Adele Gulfo’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Adele Gulfo's role in Bemis Company?
Adele Gulfo's role in Bemis Company is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.